Global Intravenous (IV) Ibuprofen Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 105

Published Date: 04 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

According to our (Global Info Research) latest study, the global Intravenous (IV) Ibuprofen market size was valued at USD 7250.7 million in 2022 and is forecast to a readjusted size of USD 14880 million by 2029 with a CAGR of 10.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Intravenous (IV) Ibuprofen market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Intravenous (IV) Ibuprofen market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Intravenous (IV) Ibuprofen market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Intravenous (IV) Ibuprofen market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Intravenous (IV) Ibuprofen market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravenous (IV) Ibuprofen
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravenous (IV) Ibuprofen market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids and PT. Soho Industri Pharmasi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Intravenous (IV) Ibuprofen market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    100 mg Dose
    200 mg Dose
    400 mg Dose
    800 mg Dose

Market segment by Application
    Pain
    Fever
    Inflammation

Major players covered
    Cumberland Pharmaceuticals
    Alveda Pharmaceuticals
    CSL Limited
    Sandor Medicaids
    PT. Soho Industri Pharmasi
    Germin MED
    Grifols
    Gloria Pharmaceuticals
    Al Nabeel International
    Laboratorios Valmorca

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous (IV) Ibuprofen product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous (IV) Ibuprofen, with price, sales, revenue and global market share of Intravenous (IV) Ibuprofen from 2018 to 2023.
Chapter 3, the Intravenous (IV) Ibuprofen competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous (IV) Ibuprofen breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intravenous (IV) Ibuprofen market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous (IV) Ibuprofen.
Chapter 14 and 15, to describe Intravenous (IV) Ibuprofen sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Intravenous (IV) Ibuprofen
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Intravenous (IV) Ibuprofen Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 100 mg Dose
        1.3.3 200 mg Dose
        1.3.4 400 mg Dose
        1.3.5 800 mg Dose
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Intravenous (IV) Ibuprofen Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pain
        1.4.3 Fever
        1.4.4 Inflammation
    1.5 Global Intravenous (IV) Ibuprofen Market Size & Forecast
        1.5.1 Global Intravenous (IV) Ibuprofen Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Intravenous (IV) Ibuprofen Sales Quantity (2018-2029)
        1.5.3 Global Intravenous (IV) Ibuprofen Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Cumberland Pharmaceuticals
        2.1.1 Cumberland Pharmaceuticals Details
        2.1.2 Cumberland Pharmaceuticals Major Business
        2.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
        2.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Cumberland Pharmaceuticals Recent Developments/Updates
    2.2 Alveda Pharmaceuticals
        2.2.1 Alveda Pharmaceuticals Details
        2.2.2 Alveda Pharmaceuticals Major Business
        2.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
        2.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Alveda Pharmaceuticals Recent Developments/Updates
    2.3 CSL Limited
        2.3.1 CSL Limited Details
        2.3.2 CSL Limited Major Business
        2.3.3 CSL Limited Intravenous (IV) Ibuprofen Product and Services
        2.3.4 CSL Limited Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 CSL Limited Recent Developments/Updates
    2.4 Sandor Medicaids
        2.4.1 Sandor Medicaids Details
        2.4.2 Sandor Medicaids Major Business
        2.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Product and Services
        2.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Sandor Medicaids Recent Developments/Updates
    2.5 PT. Soho Industri Pharmasi
        2.5.1 PT. Soho Industri Pharmasi Details
        2.5.2 PT. Soho Industri Pharmasi Major Business
        2.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product and Services
        2.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 PT. Soho Industri Pharmasi Recent Developments/Updates
    2.6 Germin MED
        2.6.1 Germin MED Details
        2.6.2 Germin MED Major Business
        2.6.3 Germin MED Intravenous (IV) Ibuprofen Product and Services
        2.6.4 Germin MED Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Germin MED Recent Developments/Updates
    2.7 Grifols
        2.7.1 Grifols Details
        2.7.2 Grifols Major Business
        2.7.3 Grifols Intravenous (IV) Ibuprofen Product and Services
        2.7.4 Grifols Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Grifols Recent Developments/Updates
    2.8 Gloria Pharmaceuticals
        2.8.1 Gloria Pharmaceuticals Details
        2.8.2 Gloria Pharmaceuticals Major Business
        2.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
        2.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Gloria Pharmaceuticals Recent Developments/Updates
    2.9 Al Nabeel International
        2.9.1 Al Nabeel International Details
        2.9.2 Al Nabeel International Major Business
        2.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Product and Services
        2.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Al Nabeel International Recent Developments/Updates
    2.10 Laboratorios Valmorca
        2.10.1 Laboratorios Valmorca Details
        2.10.2 Laboratorios Valmorca Major Business
        2.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product and Services
        2.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Laboratorios Valmorca Recent Developments/Updates

3 Competitive Environment: Intravenous (IV) Ibuprofen by Manufacturer
    3.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Intravenous (IV) Ibuprofen Revenue by Manufacturer (2018-2023)
    3.3 Global Intravenous (IV) Ibuprofen Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Intravenous (IV) Ibuprofen by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2022
        3.4.2 Top 6 Intravenous (IV) Ibuprofen Manufacturer Market Share in 2022
    3.5 Intravenous (IV) Ibuprofen Market: Overall Company Footprint Analysis
        3.5.1 Intravenous (IV) Ibuprofen Market: Region Footprint
        3.5.2 Intravenous (IV) Ibuprofen Market: Company Product Type Footprint
        3.5.3 Intravenous (IV) Ibuprofen Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Intravenous (IV) Ibuprofen Market Size by Region
        4.1.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Region (2018-2029)
        4.1.2 Global Intravenous (IV) Ibuprofen Consumption Value by Region (2018-2029)
        4.1.3 Global Intravenous (IV) Ibuprofen Average Price by Region (2018-2029)
    4.2 North America Intravenous (IV) Ibuprofen Consumption Value (2018-2029)
    4.3 Europe Intravenous (IV) Ibuprofen Consumption Value (2018-2029)
    4.4 Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value (2018-2029)
    4.5 South America Intravenous (IV) Ibuprofen Consumption Value (2018-2029)
    4.6 Middle East and Africa Intravenous (IV) Ibuprofen Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    5.2 Global Intravenous (IV) Ibuprofen Consumption Value by Type (2018-2029)
    5.3 Global Intravenous (IV) Ibuprofen Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    6.2 Global Intravenous (IV) Ibuprofen Consumption Value by Application (2018-2029)
    6.3 Global Intravenous (IV) Ibuprofen Average Price by Application (2018-2029)

7 North America
    7.1 North America Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    7.2 North America Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    7.3 North America Intravenous (IV) Ibuprofen Market Size by Country
        7.3.1 North America Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2029)
        7.3.2 North America Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    8.2 Europe Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    8.3 Europe Intravenous (IV) Ibuprofen Market Size by Country
        8.3.1 Europe Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2029)
        8.3.2 Europe Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Intravenous (IV) Ibuprofen Market Size by Region
        9.3.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    10.2 South America Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    10.3 South America Intravenous (IV) Ibuprofen Market Size by Country
        10.3.1 South America Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2029)
        10.3.2 South America Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Intravenous (IV) Ibuprofen Market Size by Country
        11.3.1 Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Intravenous (IV) Ibuprofen Market Drivers
    12.2 Intravenous (IV) Ibuprofen Market Restraints
    12.3 Intravenous (IV) Ibuprofen Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Intravenous (IV) Ibuprofen and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Intravenous (IV) Ibuprofen
    13.3 Intravenous (IV) Ibuprofen Production Process
    13.4 Intravenous (IV) Ibuprofen Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Intravenous (IV) Ibuprofen Typical Distributors
    14.3 Intravenous (IV) Ibuprofen Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Intravenous (IV) Ibuprofen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Intravenous (IV) Ibuprofen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Cumberland Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 4. Cumberland Pharmaceuticals Major Business
    Table 5. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    Table 6. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Cumberland Pharmaceuticals Recent Developments/Updates
    Table 8. Alveda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 9. Alveda Pharmaceuticals Major Business
    Table 10. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    Table 11. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Alveda Pharmaceuticals Recent Developments/Updates
    Table 13. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 14. CSL Limited Major Business
    Table 15. CSL Limited Intravenous (IV) Ibuprofen Product and Services
    Table 16. CSL Limited Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. CSL Limited Recent Developments/Updates
    Table 18. Sandor Medicaids Basic Information, Manufacturing Base and Competitors
    Table 19. Sandor Medicaids Major Business
    Table 20. Sandor Medicaids Intravenous (IV) Ibuprofen Product and Services
    Table 21. Sandor Medicaids Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Sandor Medicaids Recent Developments/Updates
    Table 23. PT. Soho Industri Pharmasi Basic Information, Manufacturing Base and Competitors
    Table 24. PT. Soho Industri Pharmasi Major Business
    Table 25. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product and Services
    Table 26. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. PT. Soho Industri Pharmasi Recent Developments/Updates
    Table 28. Germin MED Basic Information, Manufacturing Base and Competitors
    Table 29. Germin MED Major Business
    Table 30. Germin MED Intravenous (IV) Ibuprofen Product and Services
    Table 31. Germin MED Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Germin MED Recent Developments/Updates
    Table 33. Grifols Basic Information, Manufacturing Base and Competitors
    Table 34. Grifols Major Business
    Table 35. Grifols Intravenous (IV) Ibuprofen Product and Services
    Table 36. Grifols Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Grifols Recent Developments/Updates
    Table 38. Gloria Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 39. Gloria Pharmaceuticals Major Business
    Table 40. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product and Services
    Table 41. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Gloria Pharmaceuticals Recent Developments/Updates
    Table 43. Al Nabeel International Basic Information, Manufacturing Base and Competitors
    Table 44. Al Nabeel International Major Business
    Table 45. Al Nabeel International Intravenous (IV) Ibuprofen Product and Services
    Table 46. Al Nabeel International Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Al Nabeel International Recent Developments/Updates
    Table 48. Laboratorios Valmorca Basic Information, Manufacturing Base and Competitors
    Table 49. Laboratorios Valmorca Major Business
    Table 50. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product and Services
    Table 51. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Laboratorios Valmorca Recent Developments/Updates
    Table 53. Global Intravenous (IV) Ibuprofen Sales Quantity by Manufacturer (2018-2023) & (MT)
    Table 54. Global Intravenous (IV) Ibuprofen Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 55. Global Intravenous (IV) Ibuprofen Average Price by Manufacturer (2018-2023) & (USD/Kg)
    Table 56. Market Position of Manufacturers in Intravenous (IV) Ibuprofen, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 57. Head Office and Intravenous (IV) Ibuprofen Production Site of Key Manufacturer
    Table 58. Intravenous (IV) Ibuprofen Market: Company Product Type Footprint
    Table 59. Intravenous (IV) Ibuprofen Market: Company Product Application Footprint
    Table 60. Intravenous (IV) Ibuprofen New Market Entrants and Barriers to Market Entry
    Table 61. Intravenous (IV) Ibuprofen Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Intravenous (IV) Ibuprofen Sales Quantity by Region (2018-2023) & (MT)
    Table 63. Global Intravenous (IV) Ibuprofen Sales Quantity by Region (2024-2029) & (MT)
    Table 64. Global Intravenous (IV) Ibuprofen Consumption Value by Region (2018-2023) & (USD Million)
    Table 65. Global Intravenous (IV) Ibuprofen Consumption Value by Region (2024-2029) & (USD Million)
    Table 66. Global Intravenous (IV) Ibuprofen Average Price by Region (2018-2023) & (USD/Kg)
    Table 67. Global Intravenous (IV) Ibuprofen Average Price by Region (2024-2029) & (USD/Kg)
    Table 68. Global Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 69. Global Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 70. Global Intravenous (IV) Ibuprofen Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Global Intravenous (IV) Ibuprofen Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Global Intravenous (IV) Ibuprofen Average Price by Type (2018-2023) & (USD/Kg)
    Table 73. Global Intravenous (IV) Ibuprofen Average Price by Type (2024-2029) & (USD/Kg)
    Table 74. Global Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 75. Global Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 76. Global Intravenous (IV) Ibuprofen Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. Global Intravenous (IV) Ibuprofen Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. Global Intravenous (IV) Ibuprofen Average Price by Application (2018-2023) & (USD/Kg)
    Table 79. Global Intravenous (IV) Ibuprofen Average Price by Application (2024-2029) & (USD/Kg)
    Table 80. North America Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 81. North America Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 82. North America Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 83. North America Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 84. North America Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2023) & (MT)
    Table 85. North America Intravenous (IV) Ibuprofen Sales Quantity by Country (2024-2029) & (MT)
    Table 86. North America Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. North America Intravenous (IV) Ibuprofen Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Europe Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 89. Europe Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 90. Europe Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 91. Europe Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 92. Europe Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2023) & (MT)
    Table 93. Europe Intravenous (IV) Ibuprofen Sales Quantity by Country (2024-2029) & (MT)
    Table 94. Europe Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Intravenous (IV) Ibuprofen Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 97. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 98. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 99. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 100. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Region (2018-2023) & (MT)
    Table 101. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity by Region (2024-2029) & (MT)
    Table 102. Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value by Region (2018-2023) & (USD Million)
    Table 103. Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value by Region (2024-2029) & (USD Million)
    Table 104. South America Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 105. South America Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 106. South America Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 107. South America Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 108. South America Intravenous (IV) Ibuprofen Sales Quantity by Country (2018-2023) & (MT)
    Table 109. South America Intravenous (IV) Ibuprofen Sales Quantity by Country (2024-2029) & (MT)
    Table 110. South America Intravenous (IV) Ibuprofen Consumption Value by Country (2018-2023) & (USD Million)
    Table 111. South America Intravenous (IV) Ibuprofen Consumption Value by Country (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Type (2018-2023) & (MT)
    Table 113. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Type (2024-2029) & (MT)
    Table 114. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Application (2018-2023) & (MT)
    Table 115. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Application (2024-2029) & (MT)
    Table 116. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Region (2018-2023) & (MT)
    Table 117. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity by Region (2024-2029) & (MT)
    Table 118. Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value by Region (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value by Region (2024-2029) & (USD Million)
    Table 120. Intravenous (IV) Ibuprofen Raw Material
    Table 121. Key Manufacturers of Intravenous (IV) Ibuprofen Raw Materials
    Table 122. Intravenous (IV) Ibuprofen Typical Distributors
    Table 123. Intravenous (IV) Ibuprofen Typical Customers
List of Figures
    Figure 1. Intravenous (IV) Ibuprofen Picture
    Figure 2. Global Intravenous (IV) Ibuprofen Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Type in 2022
    Figure 4. 100 mg Dose Examples
    Figure 5. 200 mg Dose Examples
    Figure 6. 400 mg Dose Examples
    Figure 7. 800 mg Dose Examples
    Figure 8. Global Intravenous (IV) Ibuprofen Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 9. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Application in 2022
    Figure 10. Pain Examples
    Figure 11. Fever Examples
    Figure 12. Inflammation Examples
    Figure 13. Global Intravenous (IV) Ibuprofen Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Intravenous (IV) Ibuprofen Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Intravenous (IV) Ibuprofen Sales Quantity (2018-2029) & (MT)
    Figure 16. Global Intravenous (IV) Ibuprofen Average Price (2018-2029) & (USD/Kg)
    Figure 17. Global Intravenous (IV) Ibuprofen Sales Quantity Market Share by Manufacturer in 2022
    Figure 18. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Manufacturer in 2022
    Figure 19. Producer Shipments of Intravenous (IV) Ibuprofen by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 20. Top 3 Intravenous (IV) Ibuprofen Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Top 6 Intravenous (IV) Ibuprofen Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Global Intravenous (IV) Ibuprofen Sales Quantity Market Share by Region (2018-2029)
    Figure 23. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Region (2018-2029)
    Figure 24. North America Intravenous (IV) Ibuprofen Consumption Value (2018-2029) & (USD Million)
    Figure 25. Europe Intravenous (IV) Ibuprofen Consumption Value (2018-2029) & (USD Million)
    Figure 26. Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value (2018-2029) & (USD Million)
    Figure 27. South America Intravenous (IV) Ibuprofen Consumption Value (2018-2029) & (USD Million)
    Figure 28. Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value (2018-2029) & (USD Million)
    Figure 29. Global Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 30. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Type (2018-2029)
    Figure 31. Global Intravenous (IV) Ibuprofen Average Price by Type (2018-2029) & (USD/Kg)
    Figure 32. Global Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 33. Global Intravenous (IV) Ibuprofen Consumption Value Market Share by Application (2018-2029)
    Figure 34. Global Intravenous (IV) Ibuprofen Average Price by Application (2018-2029) & (USD/Kg)
    Figure 35. North America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 36. North America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 37. North America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Country (2018-2029)
    Figure 38. North America Intravenous (IV) Ibuprofen Consumption Value Market Share by Country (2018-2029)
    Figure 39. United States Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Canada Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Mexico Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Europe Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 43. Europe Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 44. Europe Intravenous (IV) Ibuprofen Sales Quantity Market Share by Country (2018-2029)
    Figure 45. Europe Intravenous (IV) Ibuprofen Consumption Value Market Share by Country (2018-2029)
    Figure 46. Germany Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. France Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. United Kingdom Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Russia Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Italy Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 52. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 53. Asia-Pacific Intravenous (IV) Ibuprofen Sales Quantity Market Share by Region (2018-2029)
    Figure 54. Asia-Pacific Intravenous (IV) Ibuprofen Consumption Value Market Share by Region (2018-2029)
    Figure 55. China Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Japan Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Korea Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. India Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Southeast Asia Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Australia Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. South America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 62. South America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 63. South America Intravenous (IV) Ibuprofen Sales Quantity Market Share by Country (2018-2029)
    Figure 64. South America Intravenous (IV) Ibuprofen Consumption Value Market Share by Country (2018-2029)
    Figure 65. Brazil Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Argentina Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity Market Share by Type (2018-2029)
    Figure 68. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity Market Share by Application (2018-2029)
    Figure 69. Middle East & Africa Intravenous (IV) Ibuprofen Sales Quantity Market Share by Region (2018-2029)
    Figure 70. Middle East & Africa Intravenous (IV) Ibuprofen Consumption Value Market Share by Region (2018-2029)
    Figure 71. Turkey Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Egypt Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Saudi Arabia Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. South Africa Intravenous (IV) Ibuprofen Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. Intravenous (IV) Ibuprofen Market Drivers
    Figure 76. Intravenous (IV) Ibuprofen Market Restraints
    Figure 77. Intravenous (IV) Ibuprofen Market Trends
    Figure 78. Porters Five Forces Analysis
    Figure 79. Manufacturing Cost Structure Analysis of Intravenous (IV) Ibuprofen in 2022
    Figure 80. Manufacturing Process Analysis of Intravenous (IV) Ibuprofen
    Figure 81. Intravenous (IV) Ibuprofen Industrial Chain
    Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 83. Direct Channel Pros & Cons
    Figure 84. Indirect Channel Pros & Cons
    Figure 85. Methodology
    Figure 86. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca

Related Reports

Global Intravenous (IV) Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Intravenous (IV) Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Intravenous (IV) Ibuprofen market size was valued at USD 7250.7 million in 2023 and is forecast to a readjusted size of USD 14880 million by 2030 with a CAGR of 10.8% during review period.

Product Tags

Intravenous (IV) Ibuprofen

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>